Assessment of the clinical efficacy of the heart spectrum blood pressure monitor for diagnosis of atrial fibrillation: An unblinded clinical trial.
Atrial fibrillation (AF) is the most common arrhythmia. The most common diagnostic method, 12-lead electrocardiogram (ECG), can record episodes of arrhythmia from which the type and severity can be determined. The Heart Spectrum Blood Pressure Monitor (P2; OSTAR Meditech Corp., New Taipei City, Taiw...
Saved in:
| _version_ | 1849715574096003072 |
|---|---|
| author | Wei-Fong Kao Sen-Kuang Hou Chun-Yao Huang Chun-Chieh Chao Chung-Chih Cheng Yi-Jung Chen |
| author_facet | Wei-Fong Kao Sen-Kuang Hou Chun-Yao Huang Chun-Chieh Chao Chung-Chih Cheng Yi-Jung Chen |
| author_sort | Wei-Fong Kao |
| collection | DOAJ |
| description | Atrial fibrillation (AF) is the most common arrhythmia. The most common diagnostic method, 12-lead electrocardiogram (ECG), can record episodes of arrhythmia from which the type and severity can be determined. The Heart Spectrum Blood Pressure Monitor (P2; OSTAR Meditech Corp., New Taipei City, Taiwan) is used to measure cardiovascular pressure change with fast Fourier transform (FFT) analysis to obtain heart rate frequency variability and accurate blood pressure data. We compared the diagnostic efficacy of the Heart Spectrum Blood Pressure Monitor to a 12-lead ECG (gold standard) for patients with AF. Three measurement methods were used in this study to analyze the heart index and compare the results with simultaneous 12-lead ECG: blood pressure; mean arterial pressure, which was calculated from individual blood pressure as a constant pressure; and a constant pressure of 60 mmHg. The physician used a 12-lead ECG and the Heart Spectrum Blood Pressure Monitor simultaneously. The Heart Spectrum Blood Pressure Monitor used FFT analysis to diagnose AF, and the findings were compared to the 12-lead ECG readings. This unblinded clinical trial was conducted in the emergency department of Taipei Medical University Hospital. Twenty-nine subjects with AF and 33 without AF aged 25 to 97 y (mean, 63.5 y) were included. Subjects who were exposed to high-frequency surgical equipment during testing, those with cardiac pacemakers or implantable defibrillators, and pregnant women were excluded. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 97%, 97%, 97%, and 97%, respectively, for method 1; 90%, 100%, 100%, and 91%, respectively, for method 2; and 100%, 94%, 94%, and 100%, respectively, for method 3. The sensitivity, specificity, PPV, and NPV for both methods ranged between 90% and 100%, indicating that the Heart Spectrum Blood Pressure Monitor can be effectively applied for AF detection. |
| format | Article |
| id | doaj-art-a1eadc09487a4fec857d826d4fa625ad |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-a1eadc09487a4fec857d826d4fa625ad2025-08-20T03:13:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01136e019885210.1371/journal.pone.0198852Assessment of the clinical efficacy of the heart spectrum blood pressure monitor for diagnosis of atrial fibrillation: An unblinded clinical trial.Wei-Fong KaoSen-Kuang HouChun-Yao HuangChun-Chieh ChaoChung-Chih ChengYi-Jung ChenAtrial fibrillation (AF) is the most common arrhythmia. The most common diagnostic method, 12-lead electrocardiogram (ECG), can record episodes of arrhythmia from which the type and severity can be determined. The Heart Spectrum Blood Pressure Monitor (P2; OSTAR Meditech Corp., New Taipei City, Taiwan) is used to measure cardiovascular pressure change with fast Fourier transform (FFT) analysis to obtain heart rate frequency variability and accurate blood pressure data. We compared the diagnostic efficacy of the Heart Spectrum Blood Pressure Monitor to a 12-lead ECG (gold standard) for patients with AF. Three measurement methods were used in this study to analyze the heart index and compare the results with simultaneous 12-lead ECG: blood pressure; mean arterial pressure, which was calculated from individual blood pressure as a constant pressure; and a constant pressure of 60 mmHg. The physician used a 12-lead ECG and the Heart Spectrum Blood Pressure Monitor simultaneously. The Heart Spectrum Blood Pressure Monitor used FFT analysis to diagnose AF, and the findings were compared to the 12-lead ECG readings. This unblinded clinical trial was conducted in the emergency department of Taipei Medical University Hospital. Twenty-nine subjects with AF and 33 without AF aged 25 to 97 y (mean, 63.5 y) were included. Subjects who were exposed to high-frequency surgical equipment during testing, those with cardiac pacemakers or implantable defibrillators, and pregnant women were excluded. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 97%, 97%, 97%, and 97%, respectively, for method 1; 90%, 100%, 100%, and 91%, respectively, for method 2; and 100%, 94%, 94%, and 100%, respectively, for method 3. The sensitivity, specificity, PPV, and NPV for both methods ranged between 90% and 100%, indicating that the Heart Spectrum Blood Pressure Monitor can be effectively applied for AF detection.https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pone.0198852/1/pone.0198852.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210217%2Fauto%2Fstorage%2Fgoog4_request&X-Goog-Date=20210217T194532Z&X-Goog-Expires=3600&X-Goog-SignedHeaders=host&X-Goog-Signature=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 |
| spellingShingle | Wei-Fong Kao Sen-Kuang Hou Chun-Yao Huang Chun-Chieh Chao Chung-Chih Cheng Yi-Jung Chen Assessment of the clinical efficacy of the heart spectrum blood pressure monitor for diagnosis of atrial fibrillation: An unblinded clinical trial. PLoS ONE |
| title | Assessment of the clinical efficacy of the heart spectrum blood pressure monitor for diagnosis of atrial fibrillation: An unblinded clinical trial. |
| title_full | Assessment of the clinical efficacy of the heart spectrum blood pressure monitor for diagnosis of atrial fibrillation: An unblinded clinical trial. |
| title_fullStr | Assessment of the clinical efficacy of the heart spectrum blood pressure monitor for diagnosis of atrial fibrillation: An unblinded clinical trial. |
| title_full_unstemmed | Assessment of the clinical efficacy of the heart spectrum blood pressure monitor for diagnosis of atrial fibrillation: An unblinded clinical trial. |
| title_short | Assessment of the clinical efficacy of the heart spectrum blood pressure monitor for diagnosis of atrial fibrillation: An unblinded clinical trial. |
| title_sort | assessment of the clinical efficacy of the heart spectrum blood pressure monitor for diagnosis of atrial fibrillation an unblinded clinical trial |
| url | https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pone.0198852/1/pone.0198852.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210217%2Fauto%2Fstorage%2Fgoog4_request&X-Goog-Date=20210217T194532Z&X-Goog-Expires=3600&X-Goog-SignedHeaders=host&X-Goog-Signature=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 |
| work_keys_str_mv | AT weifongkao assessmentoftheclinicalefficacyoftheheartspectrumbloodpressuremonitorfordiagnosisofatrialfibrillationanunblindedclinicaltrial AT senkuanghou assessmentoftheclinicalefficacyoftheheartspectrumbloodpressuremonitorfordiagnosisofatrialfibrillationanunblindedclinicaltrial AT chunyaohuang assessmentoftheclinicalefficacyoftheheartspectrumbloodpressuremonitorfordiagnosisofatrialfibrillationanunblindedclinicaltrial AT chunchiehchao assessmentoftheclinicalefficacyoftheheartspectrumbloodpressuremonitorfordiagnosisofatrialfibrillationanunblindedclinicaltrial AT chungchihcheng assessmentoftheclinicalefficacyoftheheartspectrumbloodpressuremonitorfordiagnosisofatrialfibrillationanunblindedclinicaltrial AT yijungchen assessmentoftheclinicalefficacyoftheheartspectrumbloodpressuremonitorfordiagnosisofatrialfibrillationanunblindedclinicaltrial |